Atellas, Boehringer Extend By Four Years Shared Japan Deal For Micardis
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharma and Germany's Boehringer Ingelheim have agreed to a four-year extension of their co-promotion pact for Micardis (telmisartan) blood pressure drug